Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
merimepodib epidermal growth factor receptor NA Successful target TTD Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved unknown
merimepodib epidermal growth factor receptor NA Successful target TTD Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Cancer of Head and Neck[MeSHID:D006258]
Malignant neoplasm of breast[MeSHID:D001943]		 NA approved unknown
merimepodib erbb2 tyrosine kinase receptor NA Successful target TTD Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Cancer of Head and Neck[MeSHID:D006258]
Malignant neoplasm of breast[MeSHID:D001943]		 NA approved unknown
merimepodib erbb2 tyrosine kinase receptor NA Successful target TTD Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved unknown
merimepodib inosine-5'-monophosphate dehydrogenase 1 NA Successful target TTD Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Stomach[MeSHID:D013270]
Adenocarcinoma[MeSHID:D000230]
Cancer of Head and Neck[MeSHID:D006258]
Malignant neoplasm of breast[MeSHID:D001943]		 NA approved unknown
merimepodib inosine-5'-monophosphate dehydrogenase 1 NA Successful target TTD Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved unknown
click here to return to the previous page